“…Therefore, we investigated concentration-dependent self-assembly behavior of short peptide amphiphiles (sPA 1 and 2, Scheme 1), followed by their surface modification by using bioactive silver nanoparticles (AgNPs) to develop AgNP functionalized antibacterial biomaterials. [24,25] Such AgNPs-sPA nanostructures have ability to facilitate transportation of AgNPs via cell membrane, therefore can be convenient drug-delivery agents. [25] In this study, we wished to perform self-assembly of sPA1 and 2 at different concentrations [26] , i. e., 10 μM, 100 μM, and 200 μM, followed by the formation of AgNPs.…”